CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
CRELUX and ProQinase announced that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the agreement, CRELUX and ProQinase will establish and continuously expand an off-the-shelf crystal-grade protein kinase portfolio, optimized and quality-controlled for successful crystallization. In addition, the two companies will work closely together to provide new crystal-grade protein or crystal structures, tailored to meet customers' needs.
Recombinant protein kinases, optimized for crystallization, will be produced and exclusively marketed by ProQinase, while CRELUX will continue to provide customers with crystallization and x-ray crystallography services. CRELUX will support ProQinase by performing crystallization quality control for each crystal grade protein batch. At the same time, ProQinase will grant CRELUX privileged direct access to kinase crystal-grade protein.
"This new joint crystal-grade kinase platform offers tremendous advantages: It enables us to continue to focus on our core expertise - complex structure solution - while leveraging the expertise of ProQinase to significantly strengthen our capacities in protein expression," commented Dr. Michael Schäffer, CEO of CRELUX.
Most read news
Topics
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Takara Bio and Eppendorf cooperate - Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency
University of Leicester researchers discover new fluorescent silicon nanoparticles - Research may ultimately track the uptake of drugs by the body's cells
Live-cell microscopy reveals cell migration by direct forces
PET imaging with special tracer can detect and diagnose early Alzheimer's disease
Through thick and thin - Decades-old fluid question solved
Microfluidic molecular exchanger helps control therapeutic cell manufacturing
Autonomous synthesis robot uses AI to speed up chemical discovery - Impressive ingenuity
Differentiating amino acids: Foundation for direct sequencing of individual proteins developed
Research under high pressure - Why 3,000 bars are needed to take a comprehensive look at a protein
Oxford Gene Technology and Abcodia form Partnership - Companies Combine Expertise to Advance Biomarkers for the Early Diagnosis of Pancreatic Cancer